Compare PTCT & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | VIRT |
|---|---|---|
| Founded | 1998 | 2008 |
| Country | United States | United States |
| Employees | N/A | 1027 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 4.8B |
| IPO Year | 2006 | 2014 |
| Metric | PTCT | VIRT |
|---|---|---|
| Price | $72.08 | $54.45 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 5 |
| Target Price | ★ $80.65 | $45.60 |
| AVG Volume (30 Days) | ★ 1.4M | 1.2M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.89% |
| EPS Growth | ★ 264.48 | 72.73 |
| EPS | N/A | ★ 1.99 |
| Revenue | $264,734,000.00 | ★ $3,632,118,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17.70 | $1.34 |
| P/E Ratio | ★ N/A | $27.57 |
| Revenue Growth | ★ 36.19 | 26.25 |
| 52 Week Low | $43.18 | $31.55 |
| 52 Week High | $87.50 | $55.09 |
| Indicator | PTCT | VIRT |
|---|---|---|
| Relative Strength Index (RSI) | 53.41 | 67.48 |
| Support Level | $61.59 | $32.61 |
| Resistance Level | $79.67 | N/A |
| Average True Range (ATR) | 3.55 | 1.82 |
| MACD | 0.59 | 0.31 |
| Stochastic Oscillator | 49.85 | 86.85 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.